| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |